Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1963 2
1964 4
1965 2
1969 4
1970 2
1971 1
1973 1
1974 1
1975 1
1977 2
1978 3
1980 2
1982 1
1983 2
1984 1
1985 3
1986 4
1987 4
1988 14
1989 5
1990 3
1991 3
1992 5
1993 2
1994 7
1995 13
1996 6
1997 4
1998 5
1999 6
2000 1
2001 4
2002 7
2003 11
2004 11
2005 11
2006 10
2007 6
2008 10
2009 5
2010 8
2011 17
2012 11
2013 7
2014 12
2015 9
2016 6
2017 8
2018 12
2019 9
2020 19
2021 32
2022 29
2023 25
2024 25
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Ogura T, Ando M, Miyazawa H, Tanaka T, Saijo Y, Hagiwara K, Morita S, Nukiwa T; North-East Japan Study Group. Maemondo M, et al. Among authors: kinoshita i. N Engl J Med. 2010 Jun 24;362(25):2380-8. doi: 10.1056/NEJMoa0909530. N Engl J Med. 2010. PMID: 20573926 Free article. Clinical Trial.
Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial.
Shimoi T, Sunami K, Tahara M, Nishiwaki S, Tanaka S, Baba E, Kanai M, Kinoshita I, Shirota H, Hayashi H, Nishida N, Kubo T, Mamesaya N, Ando Y, Okita N, Shibata T, Nakamura K, Yamamoto N. Shimoi T, et al. Among authors: kinoshita i. EClinicalMedicine. 2024 Feb 2;69:102447. doi: 10.1016/j.eclinm.2024.102447. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38333370 Free PMC article.
[Non-small-cell lung cancer].
Akita H, Kinoshita I. Akita H, et al. Among authors: kinoshita i. Gan To Kagaku Ryoho. 2008 May;35(5):720-4. Gan To Kagaku Ryoho. 2008. PMID: 18487906 Review. Japanese.
A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.
Sunami K, Naito Y, Saigusa Y, Amano T, Ennishi D, Imai M, Kage H, Kanai M, Kenmotsu H, Komine K, Koyama T, Maeda T, Morita S, Sakai D, Hirata M, Ito M, Kozuki T, Sakashita H, Horinouchi H, Okuma Y, Takashima A, Kubo T, Hironaka S, Segawa Y, Yakushijin Y, Bando H, Makiyama A, Suzuki T, Kinoshita I, Kohsaka S, Ohe Y, Ishioka C, Yamamoto K, Tsuchihara K, Yoshino T. Sunami K, et al. Among authors: kinoshita i. JAMA Oncol. 2024 Jan 1;10(1):95-102. doi: 10.1001/jamaoncol.2023.5120. JAMA Oncol. 2024. PMID: 38032680 Free PMC article.
Multiplex gene-panel testing for lung cancer patients.
Yatabe Y, Sunami K, Goto K, Nishio K, Aragane N, Ikeda S, Inoue A, Kinoshita I, Kimura H, Sakamoto T, Satouchi M, Shimizu J, Tsuta K, Toyooka S, Nishino K, Hatanaka Y, Matsumoto S, Mikubo M, Yokose T, Dosaka-Akita H. Yatabe Y, et al. Among authors: kinoshita i. Pathol Int. 2020 Dec;70(12):921-931. doi: 10.1111/pin.13023. Epub 2020 Sep 21. Pathol Int. 2020. PMID: 32956529 Review.
Clinical outcomes for olfactory neuroblastoma.
Nakazono A, Motegi H, Suzuki M, Nakamaru Y, Yamaguchi S, Ishi Y, Kano S, Tsushima N, Honma A, Suzuki T, Kimura S, Hamada S, Taguchi J, Shimizu Y, Mori T, Yasuda K, Aoyama H, Kinoshita I, Fujimura M, Homma A. Nakazono A, et al. Among authors: kinoshita i. Front Oncol. 2024 May 2;14:1329572. doi: 10.3389/fonc.2024.1329572. eCollection 2024. Front Oncol. 2024. PMID: 38756668 Free PMC article.
Retroperitoneal Myxofibrosarcoma: A Controversial Entity.
Yoshimoto M, Yamada Y, Ishihara S, Kohashi K, Toda Y, Ito Y, Susuki Y, Kinoshita I, Yamamoto H, Nakashima Y, Oda Y. Yoshimoto M, et al. Among authors: kinoshita i. Pathol Res Pract. 2020 Jun;216(6):152969. doi: 10.1016/j.prp.2020.152969. Epub 2020 Apr 20. Pathol Res Pract. 2020. PMID: 32345539 No abstract available.
Sugar-pendant diamines.
Mikata Y, Shinohara Y, Yoneda K, Nakamura Y, Esaki K, Tanahashi M, Brudziñska I, Hirohara S, Yokoyama M, Mogami K, Tanase T, Kitayama T, Takashiba K, Nabeshima K, Takagi R, Takatani M, Okamoto T, Kinoshita I, Doe M, Hamazawa A, Morita M, Nishida F, Sakakibara T, Orvig C, Yano S. Mikata Y, et al. Among authors: kinoshita i. J Org Chem. 2001 Jun 1;66(11):3783-9. doi: 10.1021/jo001702+. J Org Chem. 2001. PMID: 11374998
393 results